{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:46:17Z","timestamp":1769766377707,"version":"3.49.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1097\/mop.0b013e3280140613","type":"journal-article","created":{"date-parts":[[2007,3,14]],"date-time":"2007-03-14T07:51:38Z","timestamp":1173858698000},"page":"15-22","source":"Crossref","is-referenced-by-count":31,"title":["Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy"],"prefix":"10.1097","volume":"19","author":[{"given":"Marc","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Krajinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210206","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3322\/canjclin.40.6.355","article-title":"The impact of childhood cancer on the United States and the world","volume":"40","author":"Bleyer","year":"1990","journal-title":"CA Cancer J Clin"},{"key":"R2-4-20210206","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrc1800","article-title":"Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy","volume":"6","author":"Cheok","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R3-4-20210206","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.pharmtox.45.120403.100018","article-title":"Pharmacogenomics of acute leukemia","volume":"46","author":"Cheok","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R4-4-20210206","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.moh.0000231424.46148.f9","article-title":"Pharmacogenomics of acute lymphoblastic leukemia","volume":"13","author":"Kager","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"R5-4-20210206","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.293.12.1485","article-title":"Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia","volume":"293","author":"Stanulla","year":"2005","journal-title":"JAMA"},{"key":"R6-4-20210206","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2005-08-3379","article-title":"Thiopurine methyltransferase in acute lymphoblastic leukemia","volume":"107","author":"Relling","year":"2006","journal-title":"Blood"},{"key":"R7-4-20210206","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tips.2006.06.007","article-title":"TPMT, UGT1A1 and DPYD: genotyping to ensure safer cancer therapy?","volume":"27","author":"Maitland","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"R8-4-20210206","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood-2005-01-0143","article-title":"Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment","volume":"106","author":"Zaza","year":"2005","journal-title":"Blood"},{"key":"R9-4-20210206","first-page":"3","article-title":"An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents","volume":"26","author":"Calvert","year":"1999","journal-title":"Semin Oncol"},{"key":"R10-4-20210206","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00129785-200101030-00004","article-title":"Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences","volume":"1","author":"Schwahn","year":"2001","journal-title":"Am J Pharmacogenomics"},{"key":"R11-4-20210206","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jnci\/djh015","article-title":"Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate","volume":"96","author":"Sohn","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R12-4-20210206","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1093\/jn\/136.10.2653","article-title":"A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism","volume":"136","author":"Reed","year":"2006","journal-title":"J Nutr"},{"key":"R13-4-20210206","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.tpj.6500224","article-title":"Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia","volume":"4","author":"Krajinovic","year":"2004","journal-title":"Pharmacogenomics J"},{"key":"R14-4-20210206","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/0008-5472.CAN-04-2606","article-title":"Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia","volume":"65","author":"Aplenc","year":"2005","journal-title":"Cancer Res"},{"key":"R15-4-20210206","first-page":"1113","article-title":"Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia","volume":"91","author":"Costea","year":"2006","journal-title":"Haematologica"},{"key":"R16-4-20210206","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.mph.0000198269.61948.90","article-title":"Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma","volume":"28","author":"Shimasaki","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"R17-4-20210206","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1200\/JCO.2003.07.056","article-title":"Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia","volume":"21","author":"Kishi","year":"2003","journal-title":"J Clin Oncol"},{"key":"R18-4-20210206","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/14622416.6.7.673","article-title":"Pharmacogenetics of folate-related drug targets in cancer treatment","volume":"6","author":"Robien","year":"2005","journal-title":"Pharmacogenomics"},{"key":"R19-4-20210206","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.fpc.0000194423.20393.08","article-title":"Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics","volume":"16","author":"Martin","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"R20-4-20210206","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1247\/csf.20.191","article-title":"Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5\u2032-terminal regulatory region of the human gene for thymidylate synthase","volume":"20","author":"Horie","year":"1995","journal-title":"Cell Struct Funct"},{"key":"R21-4-20210206","first-page":"2898","article-title":"A novel single nucleotide polymorphism within the 5\u2032 tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity","volume":"63","author":"Mandola","year":"2003","journal-title":"Cancer Res"},{"key":"R22-4-20210206","doi-asserted-by":"crossref","first-page":"23456","DOI":"10.1074\/jbc.M600282200","article-title":"Differential stability of thymidylate synthase 3\u2032 UTR polymorphic variants regulated by AUF1","volume":"281","author":"Pullmann","year":"2006","journal-title":"J Biol Chem"},{"key":"R23-4-20210206","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.tpj.6500332","article-title":"Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis","volume":"5","author":"Krajinovic","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"R24-4-20210206","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1182\/blood-2004-11-4544","article-title":"Pharmacogenetics of outcome in children with acute lymphoblastic leukemia","volume":"105","author":"Rocha","year":"2005","journal-title":"Blood"},{"key":"R25-4-20210206","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1200\/JCO.2004.11.020","article-title":"Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia","volume":"22","author":"Relling","year":"2004","journal-title":"J Clin Oncol"},{"key":"R26-4-20210206","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1172\/JCI118409","article-title":"Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo: a rationale for high-dose methotrexate","volume":"97","author":"Masson","year":"1996","journal-title":"J Clin Invest"},{"key":"R27-4-20210206","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-1119(03)00807-2","article-title":"Identification of single nucleotide polymorphisms in the human gamma-glutamyl hydrolase gene and characterization of promoter polymorphisms","volume":"319","author":"Chave","year":"2003","journal-title":"Gene"},{"key":"R28-4-20210206","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.fpc.0000114761.78957.7e","article-title":"A substrate specific functional polymorphism of human gamma-glutamyl hydrolase alters catalytic activity and methotrexate polyglutamate accumulation in acute lymphoblastic leukaemia cells","volume":"14","author":"Cheng","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R30-4-20210206","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/505645","article-title":"Epigenetic regulation of human gamma-glutamyl hydrolase activity in acute lymphoblastic leukemia cells","volume":"79","author":"Cheng","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R31-4-20210206","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00008571-200309000-00006","article-title":"The influence of cyclin D1 (CCND1) 870A>G polymorphism and CCND1-thymidylate synthase (TS) gene\u2013gene interaction on the outcome of childhood acute lymphoblastic leukaemia","volume":"13","author":"Costea","year":"2003","journal-title":"Pharmacogenetics"},{"key":"R32-4-20210206","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1532\/IJH97.A10418","article-title":"Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population","volume":"82","author":"Hou","year":"2005","journal-title":"Int J Hematol"},{"key":"R33-4-20210206","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2004-12-4941","article-title":"Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia","volume":"106","author":"de Jonge","year":"2005","journal-title":"Blood"},{"key":"R34-4-20210206","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood.V100.10.3832","article-title":"Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia","volume":"100","author":"Laverdiere","year":"2002","journal-title":"Blood"},{"key":"R35-4-20210206","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/humu.10213","article-title":"Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms","volume":"21","author":"Bray","year":"2003","journal-title":"Hum Mutat"},{"key":"R36-4-20210206","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00129785-200404050-00006","article-title":"Polymorphisms in genes involved in the corticosteroid response and the outcome of childhood acute lymphoblastic leukemia","volume":"4","author":"Fleury","year":"2004","journal-title":"Am J Pharmacogenomics"},{"key":"R37-4-20210206","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1158\/1078-0432.CCR-04-2097","article-title":"Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia","volume":"11","author":"Tissing","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R38-4-20210206","first-page":"1279","article-title":"Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia","volume":"90","author":"Tissing","year":"2005","journal-title":"Haematologica"},{"key":"R39-4-20210206","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/sj.leu.2403521","article-title":"The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia","volume":"18","author":"Meissner","year":"2004","journal-title":"Leukemia"},{"key":"R40-4-20210206","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1200\/JCO.2001.19.5.1279","article-title":"Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia","volume":"19","author":"Davies","year":"2001","journal-title":"J Clin Oncol"},{"key":"R41-4-20210206","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.leu.2403922","article-title":"Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia","volume":"19","author":"Lehrnbecher","year":"2005","journal-title":"Leukemia"},{"key":"R42-4-20210206","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1200\/JCO.2005.01.2179","article-title":"Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Munster Trial NHL-BFM 95","volume":"23","author":"Seidemann","year":"2005","journal-title":"J Clin Oncol"},{"key":"R43-4-20210206","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00277-005-0072-2","article-title":"MTHFR 677 (C\u2192T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95","volume":"85","author":"Seidemann","year":"2006","journal-title":"Ann Hematol"},{"key":"R44-4-20210206","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1200\/JCO.2005.04.6011","article-title":"FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor","volume":"24","author":"Cheung","year":"2006","journal-title":"J Clin Oncol"},{"key":"R45-4-20210206","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2005.04.040","article-title":"Role of pharmacogenetics in irinotecan therapy","volume":"234","author":"de Jong","year":"2006","journal-title":"Cancer Lett"},{"key":"R46-4-20210206","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1182\/blood-2004-04-1552","article-title":"Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia","volume":"105","author":"Cario","year":"2005","journal-title":"Blood"},{"key":"R47-4-20210206","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.leukres.2005.10.007","article-title":"The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes","volume":"30","author":"Talby","year":"2006","journal-title":"Leuk Res"},{"key":"R48-4-20210206","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1172\/JCI22477","article-title":"Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics","volume":"115","author":"Kager","year":"2005","journal-title":"J Clin Invest"},{"key":"R49-4-20210206","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N Engl J Med"},{"key":"R50-4-20210206","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2005.03.002","article-title":"Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia","volume":"7","author":"Lugthart","year":"2005","journal-title":"Cancer Cell"},{"key":"R51-4-20210206","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.leu.2404059","article-title":"Genome-wide approach to identify risk factors for therapy-related myeloid leukemia","volume":"20","author":"Bogni","year":"2006","journal-title":"Leukemia"},{"key":"R52-4-20210206","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/ijc.21564","article-title":"Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters","volume":"118","author":"Zirn","year":"2006","journal-title":"Int J Cancer"},{"key":"R53-4-20210206","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-04-2463","article-title":"An expression signature classifies chemotherapy-resistant pediatric osteosarcoma","volume":"65","author":"Mintz","year":"2005","journal-title":"Cancer Res"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e3280140613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:36:11Z","timestamp":1620963371000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-200702000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e3280140613","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}